国产成人精品高清久久_好姑娘影视在线观看高清_99久久久久久久久_欧美涩涩网_久久国产精品91_9色网站

英國Activotec
多肽合成公司 成立于2002年

Activotec is a peptide synthesis Company providing innovative custom peptide synthesis services, peptide synthesizers and chemicals for chemical research and development.

Our mission is to establish Activotec as the partner of choice for peptide-based drug discovery.

The Company was formed in December 2002 as a spinout from the University of Southampton, with the support of Southampton University's Enterprise Office, the CEI, and benefiting from its partnership with IP Group.

Activotec's core focus is customer service whether it's instrument development and support, delivery of quality custom synthesis services or chemicals, all critical to the success of your science. Our stock of instrument parts, consumables and chemicals offers a first class commitment to customer support.

Activotec offers scientists a single point of expertise and assistance in research, design, manufacture of new, innovative and practical solutions.

Peptide Synthesizers
The Company develops and manufactures automated peptide synthesizers to sell worldwide to the peptide synthesis community. All development and production takes place at its facility in Cambridge, UK. The Activo-P11 peptide synthesizer is an easy to use and affordable instrument for synthesis of very high quality peptides on a scale from 0.05 to 2.0 mmol.

Custom Peptide Synthesis
Activotec provides a fast reliable custom peptide synthesis service, using solid and solution phase chemistry employing state of the art methodologies for the design and production of peptides for research purposes. Activotec offers custom peptide services from small research scale to large scale manufacture with a full range of C and N terminal modifications. Particular expertise focuses on difficult to synthesize sequences, non-natural modifications, and the design and synthesis of highly effective peptide immunogens.

R & D - Peptide Therapeutics
Activotec has an extensive R & D programme based on the modification and production of peptides and proteins for therapeutic use. The Company has filed a number of patent applications based on various synthesis techniques. Further patents have been filed relating to the development of novel peptide-based products for the treatment of cancer, HIV and diabetes.

The Company welcomes collaborative projects with biotechnology and pharmaceutical partners to develop new strategies for peptide and protein synthesis.

Activotec has a highly skilled team of research and production scientists, product specialists and service engineer's with unique experience in serving the scientific community.

Activotec is unique in its level of knowledge of the peptide research and development markets, and offers experienced technical, sales and marketing support. The company sells direct to the end-user community.